Skip to search.
 TSX Down 0.62% TSX Ventures Down 0.53%

Nektar Therapeutics (NKTR)

-NasdaqGS
15.98 Up 0.30(1.91%) 4:00PM EDT
|After Hours : 15.98 Up 0.00 (0.01%) 4:40PM EDT
Prev Close:15.68
Open:15.84
Bid:15.37 x 1100
Ask:16.99 x 100
1y Target Est:18.00
Beta:1.04261
Next Earnings Date: 3-May-16NKTR Earnings announcement
Day's Range:15.44 - 15.99
52wk Range:9.16 - 17.55
Volume:917,281
Avg Vol (3m):1,424,400
Market Cap:2.17B
P/E (ttm):N/A
EPS (ttm):-0.56
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
NKTRUp 1.91%2.17B
GSKUp 0.89%104.76B
ENZNDown 5.67%21.27M
BMYDown 0.30%120.12B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.92
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.01
Quarterly EPS Est (Mar-16) :-0.23
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):2.19

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nektar Therapeutics develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. Its product pipeline includes drug candidates in therapeutic areas comprising oncology, pain, anti-infectives... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback